1. Points to consider in the production and testing of new drugs and biologicals produced by recombinant DNA technology, Office of Biologics Research and Review, Center for Drugs and Biologics, Food and Drug Administration, Bethesda, MD, 1985.
2. Points to consider in the characterization of cell lines used to produce biologicals, Office of Biologics Research and Review, Food and Drug Administration, Bethesda, MD, 1987.
3. Points to consider in the characterization of cell lines used to produce biologicals, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, 1993.
4. WHO Study Group, Acceptability of cell substrates for production of biologicals, WHO Tech. Rep. Ser. 747 (1987).
5. Points to consider in the manufacture and testing of monoclonal antibody products for human use, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, 1987.